Spotlight on Capecitabine in Colorectal Cancer

By McGavin J.K.   Goa K.L.  

American Journal of Cancer, Vol. 1, Iss. 2, 2002-02 ,pp. : 145-148

Adis International

Access to resources Recommend Favorite

Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer

By Yaman Emel   Uner Aytug   Er Ozlem   Coskun Ugur   Buyukberber Suleyman   Dikilitas Mustafa   Polat Mevlude   Yamac Deniz   Kaya Ali   Yildiz Ramazan   Ozturk Banu   Benekli Mustafa  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 431-435

Humana Press, Inc

Access to resources Recommend Favorite

Oxaliplapin and Capecitabine (XELOX) Based Chemotherapy in the Treatment of Metastatic Colorectal Cancer: The Right Choice in Elderly Patients

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 9, 2013-11 ,pp. : 1344-1353

Bentham Science Publishers

Access to resources Recommend Favorite

Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer

By  

Cancer Medicine, Vol. 2045-7634, Iss. 10, 2015-10 ,pp. : 1505-1513

John Wiley & Sons Inc

Access to resources Recommend Favorite

Capecitabine, irinotecan (CAPIRI) and sunitinib in metastatic colorectal cancer

By Boers-Sonderen M. J.   Desar I. M. E.   Koopman M.   Punt C. J.   van Herpen C. M. L.  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1778-1778

Informa Healthcare

Access to resources Recommend Favorite